Non-invasive biosensors play a vital role in healthcare as they help in monitoring patient's health parameters such as blood glucose, heartbeat, blood pressure etc without actually entering the human body. They find wide applications in diagnosis and treatment of various chronic conditions such as diabetes, cardiovascular diseases etc. Non-invasive biosensors provide real-time information on patient's health condition which helps physicians to promptly address any issues. The growing prevalence of lifestyle diseases and growing elderly population who require close monitoring is driving the demand for non-invasive biosensors across the globe.

The global Non-invasive Biosensors Market is estimated to be valued at US$ 29.84 Bn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
Rising Demand for Continuous Monitoring in Healthcare
One of the major market opportunities for non-invasive biosensors is the rising demand for continuous monitoring in healthcare. Non-invasive biosensors allow for continuous monitoring of vital health parameters without any patient discomfort. This helps in early detection of health abnormalities and prompt treatment. With growing emphasis on preventive healthcare and remote patient monitoring, the demand for devices and solutions that enable continuous monitoring is increasing rapidly. The ability of non-invasive biosensors to monitor patients remotely in homecare settings and ambulatory care is fueling their adoption. The continuous monitoring application of non-invasive biosensors is expected to boost the market growth over the forecast period.

Porter's Analysis

Threat of new entrants: Low capital requirements and availability of new technologies has increased threat of new entrants in the non-invasive biosensors market.

Bargaining power of buyers: Large number of players has increased bargaining power of buyers in the market.

Bargaining power of suppliers: High dependence of players on raw material suppliers has increased bargaining power of suppliers.

Threat of new substitutes: Emergence of new non-invasive technologies poses threat of substitution.

Competitive rivalry: Intense competition among existing players to capture more market share has increased competitive rivalry.

SWOT Analysis

Strengths: Growing demand for wearable and point of care devices. Ability to monitor various health conditions non-invasively.

Weaknesses: Accuracy and reliability issues compared to invasive methods. Need for frequent calibration.

Opportunities: Untapped emerging economies. Integration with IOT and cloud computing.

Threats: Stringent regulatory approvals. Threat from alternate technologies.

Key Takeaways

The global Non-Invasive Biosensors Market Growth is expected to witness high growth during 2023-2030. The global Non-invasive Biosensors Market is estimated to be valued at US$ 29.84 Bn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030.

North America holds the major share of the market currently owing to presence of major players and technological advancements in the region. The Asia Pacific region is expected to grow at the fastest pace over the forecast years due to increasing health awareness, medical tourism and rising disposable income. Growing elderly population, rising prevalence of chronic diseases and shift towards home healthcare are driving the North America non-invasive biosensors market.

Key players operating in the non-invasive biosensors market are Thermax Limited, Armstrong International Inc., Stork Thermeq B.V., Alfa Laval AB, and Kelvion Holding GmbH. Thermax Limited specializes in heat transfer equipment and is one of the leading players in the market.

For more insights, read- https://www.ukwebwire.com/non-invasive-biosensors-market-trends-size-and-share-analysis-2/